Protective effect of tanshinone IIA on the early stage of experimental diabetic nephropathy

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 2, 2009, Pages 220-224

  Kim, Su Kang ^a   Jung, Kyung Hee ^a   Lee, Byung Cheol ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Advanced glycation end product; Angiotensin II; Collagen IV; Diabetic nephropathy; Tanshinone IIA; Transforming growth factor 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; COLLAGEN TYPE 4; GLUCOSE; STREPTOZOCIN; TANSHINONE IIA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; KIDNEY FAILURE; KIDNEY HYPERTROPHY; NONHUMAN; RAT; RENAL PROTECTION; SALVIA MILTIORRHIZA; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; KIDNEY; MACROPHAGES; MONOCYTES; NEUTROPHIL INFILTRATION; PHENANTHRENES; PROTECTIVE AGENTS; PROTEINURIA; RATS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 60749116974     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.220     Document Type: Article

References (34)

1. Cooper M. E., Gilbert R. E., Epstein M., Metabolism, 47, 3-6 (1998).
2. Mauer S. M., Steffes M. W., Ellis E. N., Sutherland D. E., Brown D. M., Goetz F. C., J. Clin. Invest., 74, 1143-1155 (1984).
3. Monnier V. M., Sell D. R., Nagaraj R. H., Miyata S., Grandhee S., Odetti P., Ibrahim S. A., Diabetes, 41 (Suppl. 2), 36-41 (1992).
4. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G. E., Striker L. J., Proc. Natl. Acad. Sci. U.S.A., 89, 2873-2877 (1992).
5. Throckmorton D. C., Brogden A. P., Min B., Rasmussen H., Kashgarian M., Kidney Int., 48, 111-117 (1995).
6. Miyata T., van Ypersele de Strihou C., Ueda Y., Ichimori K., Inagi R., Onogi H., Ishikawa N., Nangaku M., Kurokawa K., J. Am. Soc. Nephrol., 13, 2478-2487 (2002).
7. Jang S. I., Jeong S. I., Kim K. J., Kim H. J., Yu H. H., Park R., Kim H. M., You Y. O., PlantaMed., 69, 1057-1059 (2003).
8. Zhou L., Zuo Z., Chow M. S., J. Clin. Pharmacol., 45, 1345-1359 (2005).
9. Niu X. L., Ichimori K., Yang X., Hirota Y., Hoshiai K., Li M., Nakazawa H., Free Radic. Res., 33, 305-312 (2000).
10. Wang A. M., Sha S. H., Lesniak W., Schacht J., Antimicrob. Agents Chemother., 47, 1836-1841 (2003).
11. Takahashi K., Ouyang X., Komatsu K., Nakamura N., Hattori M., Baba A., Azuma J., Biochem. Pharmacol., 64, 745-749 (2002).
12. Xia W. J., Yang M., Fok T. F., Li K., Chan W. Y., Ng P. C., Ng H. K., Chik K. W., Wang C. C., Gu G. J., Woo K. S., Fung K. P., Pediatr. Res., 58, 784-790 (2005).
13. Lam B. Y., Lo A. C., Sun X., Luo H. W., Chung S. K., Sucher N. J., Phytomedicine, 10, 286-291 (2003).
14. Kwak H. B., Yang D., Ha H., Lee J. H., Kim H. N., Woo E. R., Lee S., Kim H. H., Lee Z. H., Exp. Mol. Med., 38, 256-264 (2006).
15. Sugaru E., Sakai M., Horigome K., Tokunaga T., Kitoh M., Hume W. E., Nagata R., Nakagawa T., Taiji M., Am. J. Physiol. Renal. Physiol., 289, F998-F1004 (2005).
16. Parving H. H., Kidney Int., 60, 2041-2055 (2001).
17. Wolf G., Reinking R., Zahner G., Stahl R. A., Shankland S. J., Diabetologia, 46, 1090-1099 (2003).
18. Song F., Qi X., Chen W., Jia W., Yao P., Nussler A. K., Sun X., Liu L., Eur. J. Nutr., 46, 61-69 (2007).
19. Qi X. M., Wu G. Z., Wu Y. G., Lin H., Shen J. J., Lin S. Y., Nephron Exp. Nephrol., 104, e147-157 (2006).
20. Mogensen C. E., N. Engl. J. Med., 310, 356-360 (1984).
21. Zhang Y., Chen B., Hou X. H., Guan G. J., Liu G., Liu H. Y., Li X. G., Chin. Med. J. (Engl.), 120, 988-995 (2007).
22. Allard J., Buleon M., Cellier E., Renaud I., Pecher C., Praddaude F., Conti M., Tack I., Girolami J. P., Am. J. Physiol. Renal Physiol., 293, F1083-F1092 (2007).
23. Vlassara H., Striker L. J., Teichberg S., Fuh H., Li Y. M., Steffes M., Proc. Natl. Acad. Sci. U.S.A., 91, 11704-11708 (1994).
24. Fukami K., Ueda S., Yamagishi S., Kato S., Inagaki Y., Takeuchi M., Motomiya Y., Bucala R., Iida S., Tamaki K., Imaizumi T., Cooper M. E., Okuda S., Kidney Int., 66, 2137-2147 (2004).
25. Kagami S., Border W. A., Miller D. E., Noble N. A., J. Clin. Invest., 93, 2431-2437 (1994).
26. Mathiesen E. R., Hommel E., Giese J., Parving H. H., BMJ, 303, 81- 87 (1991).
27. ACE Inhibitors in Diabetic Nephropathy Trialist Group, Ann. Intern. Med., 134, 370-379 (2001).
28. The EUCLID Study Group, Lancet, 349, 1787-1792 (1997).
29. Chen S., Jim B., Ziyadeh F. N., Semin. Nephrol., 23, 532-543 (2003).
30. Sharma K., Ziyadeh F. N., Semin. Nephrol., 17, 80-92 (1997).
31. Ha H., Yu M. R., Lee H. B., Kidney Int., 59, 463-170 (2001).
32. Zhan C., Tao X., Tian C., Xiong W., Zheng Z., Chinese Journal of Clinical Rehabilitation, 9, 254-256 (2005).
33. Fang Z. Y., Lin R., Yuan B. X., Yang G. D., Liu Y., Zhang H., J. Ethnopharmacol., 115, 217-222 (2008).
34. Duffield J. S., Clin. Sci. (London), 104, 27-38 (2003).